Cargando…

Development and validation of a new method for visual acuity assesment on tablet in pediatric population: eMOVA test

BACKGROUND: Amblyopia is a major public health concern. Its screening and management require reliable methods of visual acuity assessment. New technologies offer nowadays many tests available on different app stores for smartphone or tablet but most of them often lack of scientific validation for a...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoll, Noémie, Di Foggia, Elsa, Speeg-Schatz, Claude, Meunier, Hélène, Rimele, Adam, Ancé, Pascal, Moreau, Pierre-Henri, Sauer, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020062/
https://www.ncbi.nlm.nih.gov/pubmed/35439959
http://dx.doi.org/10.1186/s12886-022-02360-8
_version_ 1784689449192390656
author Stoll, Noémie
Di Foggia, Elsa
Speeg-Schatz, Claude
Meunier, Hélène
Rimele, Adam
Ancé, Pascal
Moreau, Pierre-Henri
Sauer, Arnaud
author_facet Stoll, Noémie
Di Foggia, Elsa
Speeg-Schatz, Claude
Meunier, Hélène
Rimele, Adam
Ancé, Pascal
Moreau, Pierre-Henri
Sauer, Arnaud
author_sort Stoll, Noémie
collection PubMed
description BACKGROUND: Amblyopia is a major public health concern. Its screening and management require reliable methods of visual acuity assessment. New technologies offer nowadays many tests available on different app stores for smartphone or tablet but most of them often lack of scientific validation for a medical use. The aim of our study was to attempt validating a tablet-based near visual acuity test adapted to the pediatric population: the eMOVA test (electronic Measurement Of Visual Acuity) by comparing visual acuity measured with more conventional test. METHODS: A cohort of 100 children aged 3 to 8 attending the ophthalmic-pediatric for eye examination between September 2016 and June 2017 were included in the study. Near visual acuity was assessed on participants using both the eMOVA test and a Standard test (Rossano-Weiss test). Duration of each test, its comprehension, its acceptability and the attention of the child during the test was also investigated. RESULTS: The eMOVA test overestimated near visual acuity by 0.06 logMAR. This difference, statistically significant, was not clinically relevant. The duration of the eMOVA test was longer than the reference test, but less discomfort and preferred by children and their parents compared to standard tests. CONCLUSION: The eMOVA test appears as a reliable test to assess near visual acuity in children. By its portability and efficiency, this application proved to be a relevant tool to be used for children eye examination in daily routine at the hospital.
format Online
Article
Text
id pubmed-9020062
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90200622022-04-21 Development and validation of a new method for visual acuity assesment on tablet in pediatric population: eMOVA test Stoll, Noémie Di Foggia, Elsa Speeg-Schatz, Claude Meunier, Hélène Rimele, Adam Ancé, Pascal Moreau, Pierre-Henri Sauer, Arnaud BMC Ophthalmol Research Article BACKGROUND: Amblyopia is a major public health concern. Its screening and management require reliable methods of visual acuity assessment. New technologies offer nowadays many tests available on different app stores for smartphone or tablet but most of them often lack of scientific validation for a medical use. The aim of our study was to attempt validating a tablet-based near visual acuity test adapted to the pediatric population: the eMOVA test (electronic Measurement Of Visual Acuity) by comparing visual acuity measured with more conventional test. METHODS: A cohort of 100 children aged 3 to 8 attending the ophthalmic-pediatric for eye examination between September 2016 and June 2017 were included in the study. Near visual acuity was assessed on participants using both the eMOVA test and a Standard test (Rossano-Weiss test). Duration of each test, its comprehension, its acceptability and the attention of the child during the test was also investigated. RESULTS: The eMOVA test overestimated near visual acuity by 0.06 logMAR. This difference, statistically significant, was not clinically relevant. The duration of the eMOVA test was longer than the reference test, but less discomfort and preferred by children and their parents compared to standard tests. CONCLUSION: The eMOVA test appears as a reliable test to assess near visual acuity in children. By its portability and efficiency, this application proved to be a relevant tool to be used for children eye examination in daily routine at the hospital. BioMed Central 2022-04-19 /pmc/articles/PMC9020062/ /pubmed/35439959 http://dx.doi.org/10.1186/s12886-022-02360-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Stoll, Noémie
Di Foggia, Elsa
Speeg-Schatz, Claude
Meunier, Hélène
Rimele, Adam
Ancé, Pascal
Moreau, Pierre-Henri
Sauer, Arnaud
Development and validation of a new method for visual acuity assesment on tablet in pediatric population: eMOVA test
title Development and validation of a new method for visual acuity assesment on tablet in pediatric population: eMOVA test
title_full Development and validation of a new method for visual acuity assesment on tablet in pediatric population: eMOVA test
title_fullStr Development and validation of a new method for visual acuity assesment on tablet in pediatric population: eMOVA test
title_full_unstemmed Development and validation of a new method for visual acuity assesment on tablet in pediatric population: eMOVA test
title_short Development and validation of a new method for visual acuity assesment on tablet in pediatric population: eMOVA test
title_sort development and validation of a new method for visual acuity assesment on tablet in pediatric population: emova test
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020062/
https://www.ncbi.nlm.nih.gov/pubmed/35439959
http://dx.doi.org/10.1186/s12886-022-02360-8
work_keys_str_mv AT stollnoemie developmentandvalidationofanewmethodforvisualacuityassesmentontabletinpediatricpopulationemovatest
AT difoggiaelsa developmentandvalidationofanewmethodforvisualacuityassesmentontabletinpediatricpopulationemovatest
AT speegschatzclaude developmentandvalidationofanewmethodforvisualacuityassesmentontabletinpediatricpopulationemovatest
AT meunierhelene developmentandvalidationofanewmethodforvisualacuityassesmentontabletinpediatricpopulationemovatest
AT rimeleadam developmentandvalidationofanewmethodforvisualacuityassesmentontabletinpediatricpopulationemovatest
AT ancepascal developmentandvalidationofanewmethodforvisualacuityassesmentontabletinpediatricpopulationemovatest
AT moreaupierrehenri developmentandvalidationofanewmethodforvisualacuityassesmentontabletinpediatricpopulationemovatest
AT sauerarnaud developmentandvalidationofanewmethodforvisualacuityassesmentontabletinpediatricpopulationemovatest